Dangerous Drugs Lawsuits News

Astra starts key study for new lung cancer drug
Reuters Health - LONDON (Reuters) - AstraZeneca Plc has started recruiting patients for a pivotal phase II/III clinical study of its experimental lung cancer drug AZD2171, Europe's third-biggest drug maker said on Wednesday. trials of a dual-action pill called Zactima, also in

New Impotence Drug Under Review
Grand Junction Daily Sentinel - New Impotence Drug Under Review FRIDAY, Nov. 18 (HealthDay News) -- There's a new, potentially faster-acting competitor on the horizon for Viagra (and Levitra and Cialis) in the battle against impotence. PDE5 than other drugs in its class. Avanafil's great advantage for Because of that fast action, 'the duration of side effects presumably

Carvedilol May Improve Heart Failure and Help Prevent Sudden Death
Medical News Today - shows that Carvedilol, a cardiovascular drug, could be useful in reducing significant anti-arrhythmic action. Compared to other drugs in the same class, researchers say Carvedilol

Streets of slaughter
Courier Mail - 23nov05 QUEENSLAND is reeling from the worst period of road carnage in memory, with 10 dead in seven accidents in just 27 hours. It is expected to make an announcement next week which could include trialling drug-testing of drivers Atkinson was at a loss to recall a worse period on the roads

Body parts doc smelled trouble
New York Daily News - A Colorado doctor is emerging as a key whistleblower in the Brooklyn body-snatching probe. Dr. The federal Food and Drug Administration has announced a recall and quarantine of all products sold by received transplants of the body parts under recall. Bauer said his own

Drugmaker Merck needs a magic pill
USA Today - A: It's been a nasty year or so for the legions of people who own shares of giant drugmaker Merck. recall of the company's popular Vioxx painkiller, a dry new-product pipeline and intense competition from both generic drug

ADD Drug Loses FDA Approval
CBS News - (AP) The FDA has withdrawn approval for a drug used to treat attention deficit hyperactivity disorder because it has been associated with liver problems, including death, agency officials said Monday. and the involved drug companies to fail to institute an immediate recall of these dangerous